b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC1488829/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488829/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Virology Journal" /><meta name="citation_title" content="Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice" /><meta name="citation_authors" content="Rajeswari Singam, Prasanna K Jena, Sumita Behera, Gary R Hellermann, Richard F Lockey, Dennis Ledford, Shyam S Mohapatra" /><meta name="citation_date" content="2006" /><meta name="citation_volume" content="3" /><meta name="citation_doi" content="10.1186/1743-422X-3-32" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC1488829/?report=abstract" /><meta name="citation_pmid" content="16719922" /><meta name="DC.Title" content="Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Rajeswari Singam" /><meta name="DC.Contributor" content="Prasanna K Jena" /><meta name="DC.Contributor" content="Sumita Behera" /><meta name="DC.Contributor" content="Gary R Hellermann" /><meta name="DC.Contributor" content="Richard F Lockey" /><meta name="DC.Contributor" content="Dennis Ledford" /><meta name="DC.Contributor" content="Shyam S Mohapatra" /><meta name="DC.Date" content="2006" /><meta name="DC.Identifier" content="10.1186/1743-422X-3-32" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice" /><meta property="og:type" content="article" /><meta property="og:description" content="Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in infants and is a risk factor for the development of asthma. Allergic asthmatics are more susceptible to RSV infection and viral exacerbation.Since the effectiveness of ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1488829/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC1488829/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC1488829/pdf/12985_2006_Article_139.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1BD4E8E999FD710000000006AE06AD.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC1488829</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">Virology Journal</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Virol J</span>. 2006; 3: 32. </span></div><div><span class="fm-vol-iss-date">Published online 2006 May 23. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1743-422X-3-32" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1743-422X-3-32</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC1488829</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/16719922">16719922</a></div></div></div></div><h1 class="content-title">Combined fluticasone propionate and salmeterol reduces RSV infection more effectively than either of them alone in allergen-sensitized mice</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Singam%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412708745888" co-class="co-affbox">Rajeswari Singam</a>,<sup></sup> <a href="/pubmed/?term=Jena%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412714194432" co-class="co-affbox">Prasanna K Jena</a>,<sup></sup> <a href="/pubmed/?term=Behera%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412710412336" co-class="co-affbox">Sumita Behera</a>,<sup></sup> <a href="/pubmed/?term=Hellermann%20GR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412710410208" co-class="co-affbox">Gary R Hellermann</a>,<sup></sup> <a href="/pubmed/?term=Lockey%20RF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412710407968" co-class="co-affbox">Richard F Lockey</a>,<sup></sup> <a href="/pubmed/?term=Ledford%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412710405728" co-class="co-affbox">Dennis Ledford</a>,<sup></sup> and  <a href="/pubmed/?term=Mohapatra%20SS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922" class="affpopup" co-rid="_co_idm140412715826656" co-class="co-affbox">Shyam S Mohapatra</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140412708745888"><h3 class="no_margin">Rajeswari Singam</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Singam%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Rajeswari Singam</a></div></div><div id="_co_idm140412714194432"><h3 class="no_margin">Prasanna K Jena</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Jena%20PK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Prasanna K Jena</a></div></div><div id="_co_idm140412710412336"><h3 class="no_margin">Sumita Behera</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Behera%20S%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Sumita Behera</a></div></div><div id="_co_idm140412710410208"><h3 class="no_margin">Gary R Hellermann</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Hellermann%20GR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Gary R Hellermann</a></div></div><div id="_co_idm140412710407968"><h3 class="no_margin">Richard F Lockey</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Lockey%20RF%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Richard F Lockey</a></div></div><div id="_co_idm140412710405728"><h3 class="no_margin">Dennis Ledford</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Ledford%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Dennis Ledford</a></div></div><div id="_co_idm140412715826656"><h3 class="no_margin">Shyam S Mohapatra</h3><p>Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </p><div>Find articles by <a href="/pubmed/?term=Mohapatra%20SS%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=16719922">Shyam S Mohapatra</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140412709360624_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140412709360624_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140412709360624_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140412709360624_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1">Division of Allergy and Immunology, Joy McCann Culverhouse Airway Disease Research Center, University of South Florida College of Medicine and James A. Haley VA Hospital, Tampa, FL USA </div><div><span class="fm-affl">Rajeswari Singam, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@magnisr" class="oemail">ude.fsu.csh@magnisr</a></span>.</div><div><a href="#idm140412709360624aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140412709360624_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2006 Feb 15; Accepted 2006 May 23.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140412709360624_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Singam et al; licensee BioMed Central Ltd. 2006</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC1488829/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in infants and is a risk factor for the development of asthma. Allergic asthmatics are more susceptible to RSV infection and viral exacerbation.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p2" class="p p-first-last">Since the effectiveness of corticosteroids in treating RSV infection has been controversial, we tested fluticasone propionate (FP) and salmeterol (Sal) alone versus FP plus Sal (FPS) on RSV-induced airway inflammation. Mice were sensitized and challenged with ovalbumin (OVA) and infected with RSV. Following infection they were treated with FP, Sal, or FPS intranasally and airway hyperreactivity (AHR), inflammation and RSV titers were examined.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p3" class="p p-first-last">The group treated with FPS showed significantly lower AHR compared to the group treated with FP or Sal alone. The group treated with FP alone showed slightly decreased (non-significant) AHR compared to controls. Treatment with FPS resulted in significant decreases in the percentage of eosinophils and neutrophils in bronchoalveolar lavage fluid and in lung pathology compared to FP or Sal. FP alone decreased eosinophils but not neutrophils or lymphocytes, while Sal alone decreased eosinophils and neutrophils but not lymphocytes. FPS treatment of mice infected with RSV in the absence of allergen sensitization resulted in a 50% decrease of RSV titer in the lung and a reduction in neutrophils compared to FP or Sal.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Conclusion</h3><p id="__p4" class="p p-first-last">Together, these results indicate that fluticasone in combination with salmeterol is a more effective treatment for decreasing airway hyperreactivity and inflammation than either of them alone in allergen-sensitized, RSV-infected mice.</p></div><div id="__sec5" class="sec sec-last"><h3 id="__sec5title">Electronic supplementary material</h3><p id="__p5" class="p p-first-last">The online version of this article (doi:10.1186/1743-422X-3-32) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Respiratory Syncytial Virus, Fluticasone, Fluticasone Propionate, Salmeterol, Asthma Exacerbation</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Introduction</h2><p id="__p6" class="p p-first">Asthma is a chronic lung disease with two distinct features &#x02013; airway inflammation and airway hyperresponsiveness [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731495">1</a>, <a href="#CR2" rid="CR2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731471">2</a>]. An association between viral upper-respiratory infections (URIs) and exacerbations of asthma has been reported [<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731475">3</a>, <a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731481">4</a>]. The most commonly identified viruses in these studies include rhinovirus, coronavirus, influenza virus and respiratory syncytial virus (RSV) [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731477">5</a>]. RSV is the predominant cause of URIs in infants below 2 years of age and infection may result in bronchiolitis, which is a risk factor for asthma [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731488">6</a>&#x02013;<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731493">12</a>]. RSV may constitute the earliest trigger for the development of a T-helper type 2 (Th2)-dominant immune response, which is the hallmark of immunopathology in allergic subjects including asthmatics, and also in rodent models [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731466">13</a>]. URIs cause a decrease in peak flow that lags behind upper airway symptoms by 1&#x02013;2 days, with 46% of subjects in one study reporting a two day lag in peak flow reduction [<a href="#CR14" rid="CR14" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731491">14</a>].</p><p id="__p7">A combination therapy involving a long-acting &#x003b2;2 agonist and an inhaled corticosteroid (ICS) has emerged as an effective asthma management strategy to control persistent asthma [<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731482">15</a>]. A combination of salmeterol (Sal) and fluticasone propionate (FP) was found to be superior to either of them alone [<a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731486">16</a>, <a href="#CR17" rid="CR17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731479">17</a>]. The combination is also significantly more effective than montelukast plus FP or monotherapy with inhaled budesonide [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731485">18</a>]. The increased effectiveness of FPS has been attributed to increased activation and translocation to the nucleus of glucocorticoid receptors [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731473">19</a>, <a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731489">20</a>]. However, the effect of these drugs on viral exacerbation in allergic asthmatics has not been studied.</p><p id="__p8">The conclusion of the Cochrane Review of available controlled trials of ICS in children with a history of mild episodic viral wheeze was that high dose ICS was partially effective for the treatment of mild episodic viral wheeze of childhood [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845248824">21</a>]. Since URIs induce exacerbations, &#x003b2;2-agonists may be of specific value in reducing such exacerbations. In an <em>in vitro</em> study of <em>Pseudomonas aeruginosa</em> infection, a combination of FP and Sal reduced infection and preserved ciliated cells to a greater degree than either alone suggesting synergy between the two agents [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731478">22</a>]. Because 80&#x02013;85% of asthma exacerbations in children are associated with viral infections, early intervention with a combination therapy should have beneficial effects on viral asthma exacerbations.</p><p id="__p9" class="p p-last">Since virus-induced exacerbation is accompanied by airway inflammation, we reasoned that the combination of a steroid and a &#x003b2;-2 agonist might provide protection from severe RSV infection and the ensuing asthma exacerbation. This hypothesis was tested in a mouse model of allergen sensitization and RSV infection using OVA as the allergen [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731468">1</a>]. Mice with chronic or acute sensitization to OVA were RSV infected and then treated with FP or Sal or the two together (FPS). Airway hyperreactivity (AHR) and pulmonary inflammation were measured five days after infection. The results show that the combination of FP and Sal provides significant protection in terms of both airway hyperreactivity and pulmonary inflammation compared to either of them alone.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Methods</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Animals</h3><p id="__p10" class="p p-first-last">Female BALB/c mice, 4&#x02013;6 weeks of age were obtained from Charles River and housed under pathogen-free conditions at the University of South Florida Vivarium. All treatment protocols were approved by the USF Institutional Animal Care and Use Committee (IACUC).</p></div><div id="Sec4" class="sec"><h3 id="Sec4title">RSV preparation and infection of mice</h3><p id="__p11" class="p p-first-last">The A2 strain of human RSV (American Type Culture Collection, Manassas, VA) was propagated in HEp-2 cells (American Type Culture Collection) grown in Eagle\'s minimal essential medium (Gibco) with 2% FBS. At maximum cytopathic effect, the cells were harvested in the same medium. The suspension was clarified by centrifugation at 700 &#x000d7; g for 10 min at 4&#x000b0;C and the resulting supernatant was layered onto a glycerol gradient and centrifuged at 14,000 &#x000d7; g for 3 hrs at 4&#x000b0;C. The pellet containing virus was resuspended in pre-cooled (4&#x000b0;C) buffer (0.22 &#x003bc;-filtered 50 mM HEPES (pH 7.5), 100 mM MgSO<sub>4</sub>, and 150 mM NaCl) and stored in aliquots in liquid nitrogen. Viral titers were determined by standard plaque assay combined with immunostaining for RSV. Mice were infected under light anesthesia by intranasal inoculation of RSV (5 &#x000d7; 10<sup>6</sup> PFU).</p></div><div id="Sec5" class="sec"><h3 id="Sec5title">OVA sensitization, RSV infection and drug treatment</h3><p id="__p12" class="p p-first-last">For experiments in which only a single RSV infection was used (therapeutic regimen), mice were sensitized by intraperitoneal injection (i.p.) of OVA on day 1 and by intranasal (i.n.) administration of OVA on days 7 and 9. On day 9 the mice were infected i.n. with of RSV. From day 10 to day 13 they were treated daily i.n. with fluticasone (FP) propionate, salmeterol (Sal), or the two in combination (FPS) at 10 &#x003bc;g per mouse (FP and Sal were obtained from GlaxoSmithKline). Airway hyperreactivity (AHR) was measured on day 14 and on day 15 the animals were sacrificed. For the prophylactic experiments, mice were sensitized by intraperitoneal injection (i.p.) of OVA on day 1 and by intranasal (i.n.) administration of OVA on days 9, 12 and 14. On day 19 the mice were infected i.n. with of RSV. From day 21 to day 27 mice were treated daily i.n. with FP, Sal, or the two in combination (FPS) at 10 &#x003bc;g per mouse. On day 28, mice were reinfected with RSV and then challenged i.n. with OVA. AHR was measured on day 29. On day 30 the mice were sacrificed and BAL fluid, lungs and spleens were taken. All experiments were repeated at least twice.</p></div><div id="Sec6" class="sec"><h3 id="Sec6title">Determination of airway hyperreactivity (AHR)</h3><p id="__p13" class="p p-first-last">AHR, expressed as enhanced pause (Penh), was measured in unrestrained mice by whole body plethysmography (Buxco, Troy, NY). Groups of mice (n = 4) were exposed for 5 min to nebulized PBS to establish a baseline then to increasing concentrations (6&#x02013;50 mg/ml) of nebulized methacholine (MCh; Sigma, St. Louis, MO) in PBS. Challenges were done for 5 min followed by recordings of Penh for 5 min. The Penh values were averaged and expressed for each MCh concentration as a percentage of the PBS baseline reading.</p></div><div id="Sec7" class="sec"><h3 id="Sec7title">Bronchoalveolar lavage (BAL)</h3><p id="__p14" class="p p-first-last">Lungs were lavaged using 500 &#x003bc;l of PBS and the BAL fluid was kept at 4&#x000b0;C until processed. BAL cells were centrifuged onto microscope slides by Cytospin (Shandon) and stained using the Hema3 kit (Fisher). Eosinophils, neutrophils and lymphocytes were counted from 5 different fields on 4 different slides from each group in a blinded fashion.</p></div><div id="Sec8" class="sec"><h3 id="Sec8title">Immunohistochemical analysis</h3><p id="__p15" class="p p-first-last">Lung sections were stained with hematoxylin and eosin (H&#x00026;E) and inflammation was assessed as disruption or denudation of the epithelial layer and infiltration of monocytes and lymphocytes into the perialveolar region. Lung sections were also stained with antibodies to the cell-adhesion molecule ICAM-1, the goblet cell marker Muc-5A, and the Th2 marker T1/ST2 (Santa Cruz BioTech, Santa Cruz, CA).</p></div><div id="Sec9" class="sec"><h3 id="Sec9title">Isolation of spleen cells and intracellular cytokine staining</h3><p id="__p16" class="p p-first-last">Mice were sacrificed and single-cell suspensions were prepared from the spleens and cultured for 24 to 48 hrs in DMEM with 10% FBS. Splenocytes were incubated on anti-CD3-coated or OVA-coated plates for 24 h and then treated with Golgi-Stop for 4 hr to block the secretion of cytokines. Cells were surface-stained with FITC-anti-CD4 (Research Diagnostics, Flanders, NJ) and then subjected to intracellular staining with PE-anti-IFN-&#x003b3;, -IL10 or -IL-4 antibodies (R&#x00026;D Systems, Minneapolis, MN). Cells were analyzed by flow cytometry gated on CD4<sup>+</sup> cells. The percentages of CD4<sup>+</sup> cells secreting the respective cytokines are shown.</p></div><div id="Sec10" class="sec"><h3 id="Sec10title">Measurement of cytokine levels in BAL cells</h3><p id="__p17" class="p p-first-last">Mice were sacrificed and lungs were lavaged with PBS. Aliquots of the BAL fluid were stored at -80&#x000b0;C until assayed. The concentration of IFN-&#x003b3; in the BAL was measured by ELISA using a kit (R&#x00026;D Systems, Minneapolis, MN), and the results were expressed as pg of IFN-&#x003b3; per ml of BAL fluid.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Apoptosis detection</h3><p id="__p18" class="p p-first-last">Lung sections were processed for detection of apoptosis using the DeadEnd&#x02122; Fluorometric TUNEL System assay kit (Promega). Dewaxed sections were fixed and permeablized, then incubated with terminal deoxynucleotidyl transferase to label DNA ends with FITC-dUTP. Stained sections were photographed under a fluorescent microscope.</p></div><div id="Sec12" class="sec sec-last"><h3 id="Sec12title">Statistical analysis</h3><p id="__p19" class="p p-first-last">All data were expressed as mean &#x000b1; SEM. For comparison of two different groups, Student\'s <em>t</em> test was used. Differences between groups were considered significant at <em>P</em> &#x0003c; 0.05.</p></div></div><div id="Sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec13title">Results</h2><div id="Sec14" class="sec sec-first"><h3 id="Sec14title">FPS is more effective than FP or Sal alone in preventing AHR and lung inflammation</h3><p id="__p20" class="p p-first-last">Mice were sensitized with OVA on day 1 i.p. and on day 7 and 9 i.n. On day 9 they were infected with 5 &#x000d7; 10<sup>6</sup> PFU RSV. From day 10 to 13 they were treated with 10 &#x003bc;g of FP, Sal or FP/Sal combination (FPS). AHR was measured as Penh on day 14 (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1A).</span></span><span>1A</span></a>). On day 15 the mice were sacrificed, BAL was done and a differential cell count was performed on the BAL fluid (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1B).</span></span><span>1B</span></a>). Lung sections were stained with H &#x00026;E and examined for histopathology (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1C).</span></span><span>1C</span></a>). Mice treated with FPS, FP and Sal all showed reduced eosinophil numbers but no change in neutrophils. Sal-treated mice showed an increase in the number of lymphocytes. Combination therapy resulted in a significant reduction in eosinophil number as well as lung inflammation compared to the other treatments. Lungs of allergen-sensitized and RSV-infected mice exhibited cellular infiltration with MNC and eosinophils (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.1C</span></span><span>1C</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC1488829/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140412710786704" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig1_HTML.jpg" src="/pmc/articles/PMC1488829/bin/12985_2006_Article_139_Fig1_HTML.jpg" /></div><div id="largeobj_idm140412710786704" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1488829/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC1488829/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p21"><strong>FPS is more effective than FP or Sal alone in preventing AHR and lung inflammation</strong>. Mice were sensitized with OVA and infected with RSV as described in <em>Methods</em>. From days 10 to 13 mice were treated daily with FP, Sal or FPS. AHR was measured on day 14 <strong>(A)</strong>. On day 15 the mice were sacrificed and a BAL cell differential was performed for macrophages (mac), eosinophils (eos), neutrophils (neut) and lymphocytes (lym) <strong>(B)</strong> and H &#x00026; E stained lung sections were examined for histopathology <strong>(C)</strong>. Results shown are one representative experiment of two.</p></div></div></div></div><div id="Sec15" class="sec"><h3 id="Sec15title">FPS is more effective than FP alone in reducing viral exacerbation of asthma</h3><p id="__p22" class="p p-first-last">Mice were sensitized with OVA i.p. on day 1 and on day 9, 12 and 14 i.n. On day 19 the mice were infected i.n with RSV (5 &#x000d7; 10<sup>6</sup> PFU). From day 21 to day 27, mice were treated i.n. with 10 &#x003bc;g of FP or FPS. On day 28 mice were reinfected with RSV and challenged with OVA. AHR was measured on day 29 and was lower in FPS-treated mice than those treated with FP or Sal alone (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2A).</span></span><span>2A</span></a>). On day 30 the mice were sacrificed and BAL fluid was taken and analyzed for lymphocytes, eosinophils and neutrophils by differential staining. Treatment with FPS reduced the number of eosinophils and neutrophils compared to either drug alone (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2B).</span></span><span>2B</span></a>). Lung sections showed extensive epithelial disruption and cellular infiltration in the case of RSV exposure without drug treatment. FP or S alone reduced the pathology somewhat but the combination FPS was significantly more effective (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2C).</span></span><span>2C</span></a>). The results showed that FPS significantly attenuated AHR and inflammation, as seen by the decrease in eosinophils and lymphocytes and the reduced perialveolar damage compared to control group and mice treated with FP alone.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC1488829/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140412713671280" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig2_HTML.jpg" src="/pmc/articles/PMC1488829/bin/12985_2006_Article_139_Fig2_HTML.jpg" /></div><div id="largeobj_idm140412713671280" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1488829/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC1488829/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p23"><strong>FPS is more effective than FP or Sal alone in reducing viral exacerbation of asthma</strong>. Mice were sensitized with OVA and infected with RSV as described in <em>Methods</em>. From days 21 to 27 mice were treated daily with FP, Sal or FPS. On day 28, they were reinfected with RSV and then challenged with OVA. AHR was measured on day 29 <strong>(A).</strong> On day 30 the mice were sacrificed and a BAL cell differential was performed for macrophages (mac), eosinophils (eos), neutrophils (neut) and lymphocytes (lym) <strong>(B).</strong> H &#x00026; E stained lung sections were examined for histopathology <strong>(C)</strong>. Results are from one representative experiment of two performed.</p></div></div></div></div><div id="Sec16" class="sec"><h3 id="Sec16title">Effect of FPS combination on cytokine and inflammatory marker expression</h3><p id="__p24" class="p p-first-last">To determine the effects of FPS therapy on T-cell cytokine secretion, mice were OVA-sensitized, infected with RSV and treated with FP, Sal or FPS. Mice were sacrificed after drug treatment and their splenocytes were examined for cytokine production by intracellular cytokine staining (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.3A</span></span><span>3A</span></a> &#x00026; B). Cells were stimulated with anti-CD3 in panel A and with OVA in panel B. FP increased the number of cells producing IL-10 and Sal increased cells producing IL-4, whereas FPS decreased the number of cells producing IL-10, IL-4 and IFN-&#x003b3;. Lung epithelial cells respond to inflammatory cytokines by expressing specific cell markers such as the intracellular adhesion molecule, ICAM-1, and the mucin gene, MUC-5A. Fig. <a href="/pmc/articles/PMC1488829/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.4</span></span><span>4</span></a> shows the results of an immunohistochemical analysis for ICAM-1 and Muc-5A in mouse lung sections. RSV infection increased the expression of ICAM-1 and mucin, whereas treatment with FPS decreased their expression compared to control mice. Another correlate of lung inflammation is the infiltration of T lymphocytes into the perialveolar tissue. A Th2-specific marker, T1/ST2, was used to stain lung sections, and both Sal and FPS appear to stimulate infiltration of T cells of the Th2 type into the lung (<strong>lower panel</strong>, Fig. <a href="/pmc/articles/PMC1488829/figure/Fig4/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig4" rid-ob="ob-Fig4" co-legend-rid="lgnd_Fig4"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.4</span></span><span>4</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC1488829/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140412714255376" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig3_HTML.jpg" src="/pmc/articles/PMC1488829/bin/12985_2006_Article_139_Fig3_HTML.jpg" /></div><div id="largeobj_idm140412714255376" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1488829/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC1488829/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p25"><strong>FPS reduces production of cytokines by CD4</strong><sup><strong>+</strong></sup>\n<strong>cells</strong>. Mice were sensitized with OVA, infected with RSV then treated with FP, Sal or FPS as in Fig. 1A. They were sacrificed on day 15 and their splenocytes were examined for cytokine production by intracellular cytokine staining. Splenocytes were incubated on anti-CD3-coated plates (<strong>A</strong>) or with medium containing OVA (<strong>B</strong>) for 24 h and then treated with Golgi-Stop for 4 h to block cytokine secretion. Cells were surface-stained for CD4 and intracellularly for IFN-&#x003b3;, IL10 or IL-4. The percent of CD4-gated cells producing the respective cytokine is shown. Results are from one representative experiment of two.</p></div></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig4" co-legend-rid="lgnd_Fig4"><a href="/pmc/articles/PMC1488829/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140412714251920" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig4_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig4_HTML.jpg" src="/pmc/articles/PMC1488829/bin/12985_2006_Article_139_Fig4_HTML.jpg" /></div><div id="largeobj_idm140412714251920" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1488829/figure/Fig4/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig4"><div><a class="figpopup" href="/pmc/articles/PMC1488829/figure/Fig4/" target="figure" rid-figpopup="Fig4" rid-ob="ob-Fig4">Figure 4</a></div><!--caption a7--><div class="caption"><p id="__p26"><strong>FPS decreases expression of inflammatory markers in the lung</strong>. Mice were sensitized with OVA, infected with RSV then treated with FP, Sal or FPS. They were sacrificed on day 15 and lung sections were stained for ICAM-1, Muc-5A or T1/ST2. Arrows indicate areas of staining by specific antibodies. Results are from one representative experiment of two.</p></div></div></div></div><div id="Sec17" class="sec"><h3 id="Sec17title">FPS inhibits apoptosis of lung cells</h3><p id="__p27" class="p p-first-last">Previous work from our lab documented the apoptosis of lung cells as a consequence of OVA-induced inflammation in OVA-sensitized mice. Here we sought to determine the effect of FP and Sal or the combination on this apoptosis. Mice were OVA-sensitized, RSV-infected and treated with the various drug combinations. At the end of treatment they were sacrificed, lungs were removed and sections were examined for apoptosis using the TUNEL (terminal deoxynucleotidyl transferase nick end-labeling) assay. Fig. <a href="/pmc/articles/PMC1488829/figure/Fig5/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig5" rid-ob="ob-Fig5" co-legend-rid="lgnd_Fig5"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.5</span></span><span>5</span></a> shows a representative experiment in which apoptosis was induced in a population of cells in the lungs of OVA-sensitized, RSV-infected mice. The extent of apoptosis was reduced by treatment with FP and Sal, and especially by FPS.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig5" co-legend-rid="lgnd_Fig5"><a href="/pmc/articles/PMC1488829/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140412716211376" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig5_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig5_HTML.jpg" src="/pmc/articles/PMC1488829/bin/12985_2006_Article_139_Fig5_HTML.jpg" /></div><div id="largeobj_idm140412716211376" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1488829/figure/Fig5/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig5"><div><a class="figpopup" href="/pmc/articles/PMC1488829/figure/Fig5/" target="figure" rid-figpopup="Fig5" rid-ob="ob-Fig5">Figure 5</a></div><!--caption a7--><div class="caption"><p id="__p28"><strong>FPS decreases apoptosis in the lung</strong>. Mice were sensitized with OVA, infected with RSV then treated with FP, Sal or FPS. They were sacrificed on day 15 and lung sections were analyzed for apoptotic cells by TUNEL assay. DAPI stains nuclear DNA. Results are from one representative experiment of two.</p></div></div></div></div><div id="Sec18" class="sec sec-last"><h3 id="Sec18title">FPS decreases RSV titer and increases IFN-&#x003b3; production</h3><p id="__p29" class="p p-first-last">Two groups of mice were sensitized with OVA i.p. and then prophylactically treated with FP, Sal or FPS prior to infection with RSV. Three days after infection, they were sacrificed. Lungs were removed from one group of mice, homogenized and the titer of RSV determined by plaque assay. BAL fluid was taken from the second group and analyzed by ELISA for IFN-&#x003b3;. The decreased burden of virus in the lung tissue of FPS-treated mice was matched by an increase in secreted IFN-&#x003b3; in BAL fluid (Fig. <a href="/pmc/articles/PMC1488829/figure/Fig6/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig6" rid-ob="ob-Fig6" co-legend-rid="lgnd_Fig6"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.6).</span></span><span>6</span></a>). Increased IFN-&#x003b3; production could, at least in part, account for the reduction in RSV titer.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig6" co-legend-rid="lgnd_Fig6"><a href="/pmc/articles/PMC1488829/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140412711194160" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig6_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12985_2006_Article_139_Fig6_HTML.jpg" src="/pmc/articles/PMC1488829/bin/12985_2006_Article_139_Fig6_HTML.jpg" /></div><div id="largeobj_idm140412711194160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC1488829/figure/Fig6/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig6"><div><a class="figpopup" href="/pmc/articles/PMC1488829/figure/Fig6/" target="figure" rid-figpopup="Fig6" rid-ob="ob-Fig6">Figure 6</a></div><!--caption a7--><div class="caption"><p id="__p30"><strong>FPS reduction in RSV titer correlates with increased IFN-&#x003b3; production</strong>. Two groups of mice were sensitized with OVA, and then prophylactically treated with FP, Sal or FPS prior to infection with RSV. Three days after infection, they were sacrificed. Homogenates of lungs from one group of mice were assayed for RSV titer, and BAL fluid from the second group was assayed for IFN-&#x003b3;. Results are from one representative experiment of two.</p></div></div></div></div></div><div id="Sec19" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec19title">Discussion</h2><p id="__p31" class="p p-first">Our goal in this study was to determine if the combination of a corticosteroid and a long-acting &#x003b2;2-agonist was more effective in reducing RSV-induced asthma exacerbation than either drug alone. Here we demonstrate a reduction in lung inflammation in OVA-allergic mice infected with RSV after treatment with combined fluticasone and salmeterol. Eosinophil migration to the lung is characteristically seen during RSV-induced exacerbation of asthma [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731494">23</a>], and both fluticasone and salmeterol reduced the eosinophil numbers in BAL fluid; but the combination of the two drugs was most effective. The basis of this synergy and whether the combination will be effective in infants and children affected by exposure to both viruses and allergens is unclear.</p><p id="__p32">One important finding of this study is that irrespective of the frequency of RSV infection, the FPS combination therapy was effective and significantly decreased AHR as measured by % Penh. Also, in studies in which mice were infected twice with RSV, FPS decreased AHR more than FP alone. These results are in agreement with previous reports, where steroid or &#x003b2;2-agonists alone was found to be partially effective in RSV infection and viral induced asthma [<a href="#CR24" rid="CR24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731487">24</a>&#x02013;<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731474">26</a>]. Consistent with the AHR data, there was a substantial reduction in pulmonary inflammation irrespective of the frequency of RSV infection. Of note is that in experiments where mice sensitized with OVA received one RSV infection, there was a decrease in eosinophils but an increase in lymphocytes. In contrast, OVA-sensitized mice that had two RSV infections before FP showed an increase in neutrophils. This is probably due to the resistance of neutrophils to corticosteroids and to the generation of a greater number of infiltrating neutrophils by the repeated RSV infection. The former possibility is consistent with the findings that neutrophilic asthma is resistant to treatment by FP [<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731496">27</a>]. This suggests that addition of the long-acting beta agonist is the agent primarily affecting recruitment of neutrophils in the combination.</p><p id="__p33">Furthermore, single versus double RSV infection induced significant differences in the expression of specific cytokines such as IL-10 and IL-4. RSV infection in BALB/c mice has been shown to increase a variety of cytokines and chemokines including TNF-&#x003b1;, IFN-&#x003b3;, IL-6, IL-4, IL-10, RANTES, macrophage inflammatory protein-1 alpha, and eotaxin [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731470">28</a>]. Mice with a single infection showed an increased percentage of IL-10-producing cells perhaps indicative of greater stimulation of the innate immune system [<a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731492">29</a>]. Treatment with salmeterol alone resulted in a significantly higher percentage of IL-4-producing cells characteristic of the Th2-type response observed in human infants suffering from acute RSV bronchiolitis [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731469">30</a>] while FPS decreased both IL-10 and IL-4. The numbers of cytokine-producing cells in splenocyte cultures are in agreement with the increased number of Th2-like cells seen in lung sections from salmeterol-treated mice. In mice infected twice with RSV, FPS reduced IL-10 but not IL-4 compared to FP or salmeterol alone-. This is consistent with our previous finding that allergic mice with two RSV infections had an increase in the number of cells producing IL-4 and IL-13 [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731480">1</a>]. Increased IL-10 production has been associated with recurrent wheezing in children hospitalized for RSV bronchiolitis [<a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731484">31</a>, <a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731483">32</a>].</p><p id="__p34">Another significant observation is the differential effect of FP and Sal on inflammatory markers. FP treatment caused an increase in ICAM-1 expression whereas Sal showed a small decrease. Treatment with the combination resulted in a decrease of ICAM-1 expression. This observation is consistent with previous reports which showed that FPS combination decreased ICAM-1 expression in human lung fibroblast cells [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731472">33</a>, <a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731467">34</a>]. The expression of MUC-5A, which is a marker for mucus production, was also decreased by combined FPS treatment, but not significantly by either FP or Sal alone. Staining for the Th2-specific marker, T1/ST2 demonstrated the RSV-induced infiltration of Th2 cells. While treatment with FP increased ICAM-1 and MUC-5 expression, Th2 infiltration in lungs of FP-treated mice was decreased. In contrast, treatment with Sal did not inhibit Th2 infiltration. The combination FPS treatment decreased Th2 infiltration compared with Sal indicating that steroids and &#x003b2;<sub>2</sub>-agonists differentially affect inflammatory parameters, but that the two in combination can effectively reduce RSV-induced lung inflammation.</p><p id="__p35">Apoptosis of lymphocytes in the lung is a characteristic feature of RSV bronchiolitis and may increase the severity of the disease [<a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731490">35</a>]. Our results indicated that compared to lungs of mice sensitized with OVA in the presence or absence of RSV infection, lungs of mice treated with either FP or Sal and the combination FPS showed a decreased number of apoptotic cells. The FPS combination shows even fewer apoptotic cells compared to FP or Sal alone suggesting the greater effectiveness of the combination treatment. The reason for this is unclear, but it may be due to the fact that treatment with FP or Sal decreases infiltration of inflammatory cells to the lungs. This idea is consistent with the report that FPS increases apoptosis of peripheral blood T cells [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731497">36</a>].</p><p id="__p36">Treatment with FP plus Sal decreases lung inflammation and examination of lung homogenates for RSV revealed a reduction in virus titer in the mice treated with FPS, suggesting that the combination treatment exerts additional antiviral effects. The measurement of IFN-&#x003b3; in BAL fluid showed an increased production of IFN-&#x003b3; in the lungs of mice treated with FPS therapy. Thus, the observed reduction in RSV titer may be due to increased IFN-&#x003b3; levels in the lungs induced by the FPS combination therapy.</p><p id="__p37" class="p p-last">Although a number of experimental approaches are under investigation for the treatment of RSV infection [<a href="#CR37" rid="CR37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731476">37</a>&#x02013;<a href="#CR40" rid="CR40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_844731465">40</a>], the possibility that such infection can be managed using already available therapies is an important finding. The results of this -study show that OVA-sensitized mice receiving fluticasone plus salmeterol had a significant reduction in RSV-induced inflammation and RSV titers compared to those receiving the drugs individually. Our results suggest that the use of a combination therapy can be very effective in reducing virally-induced asthma exacerbations.</p></div><div id="idm140412715670432" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140412715670432title">Acknowledgements</h2><div class="sec"><p id="__p62">SSM, RFL and DL designed the study and assisted in data evaluation and presentation. RS prepared RSV, performed infections, drug treatments, AHR measurements, and immunohistochemical analysis. PKJ performed OVA sensitization and RSV infection. SB obtained BAL fluid, isolated splenocytes and did cytokine assays. GRH performed apoptosis assays.</p></div></div><div id="idm140412708897152" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140412708897152title">Abbreviations</h2><div class="bk-sec"><div><table class="default-table glossary"><tbody><tr><td>FP</td><td>fluticasone propionate</td></tr><tr><td>Sal</td><td>salmeterol</td></tr><tr><td>FPS</td><td>fluticasone plus salmeterol</td></tr><tr><td>RSV</td><td>respiratory syncytial virus</td></tr><tr><td>AHR</td><td>airway hyperreactivity</td></tr><tr><td>ICS</td><td>inhaled corticosteroids</td></tr><tr><td>OVA</td><td>ovalbumin</td></tr><tr><td>BAL</td><td>bronchoalveolar lavage</td></tr><tr><td>Th2</td><td>T helper cell type 2</td></tr><tr><td>URI</td><td>upper respiratory infection</td></tr><tr><td>PFU</td><td>plaque-forming units</td></tr><tr><td>i.p.</td><td>intraperitoneal</td></tr><tr><td>i.n.</td><td>intranasal</td></tr><tr><td>Penh</td><td>enhanced pause</td></tr><tr><td>MCh</td><td>methacholine.</td></tr></tbody></table></div></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec20" class="sec sec-first"><h3 id="Sec20title">Authors&#x02019; original submitted files for images</h3><p id="__p38" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC1488829/bin/12985_2006_139_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(61K, pdf)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC1488829/bin/12985_2006_139_MOESM2_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(61K, pdf)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC1488829/bin/12985_2006_139_MOESM3_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(23K, pdf)</sup></span><span class="sup-box" id="MOESM4"><a href="/pmc/articles/PMC1488829/bin/12985_2006_139_MOESM4_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 4</a><sup>(120K, pdf)</sup></span><span class="sup-box" id="MOESM5"><a href="/pmc/articles/PMC1488829/bin/12985_2006_139_MOESM5_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 5</a><sup>(165K, pdf)</sup></span><span class="sup-box" id="MOESM6"><a href="/pmc/articles/PMC1488829/bin/12985_2006_139_MOESM6_ESM.pdf" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 6</a><sup>(12K, pdf)</sup></span></p></div></div><div id="idm140412715671808" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140412715671808title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140412715671680"><p id="__p60" class="p p-first"><strong>Competing interests</strong></p><p id="__p61" class="p p-last">The author(s) declare that they have no competing interests.</p></p></div></div><div id="idm140412709360624aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140412709360624aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Rajeswari Singam, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@magnisr" class="oemail">ude.fsu.csh@magnisr</a></span>.</p><p><span class="fm-affl">Prasanna K Jena, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@nnasarpj" class="oemail">ude.fsu.csh@nnasarpj</a></span>.</p><p><span class="fm-affl">Sumita Behera, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@arehebs" class="oemail">ude.fsu.csh@arehebs</a></span>.</p><p><span class="fm-affl">Gary R Hellermann, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@mrellehg" class="oemail">ude.fsu.csh@mrellehg</a></span>.</p><p><span class="fm-affl">Richard F Lockey, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@yekcolr" class="oemail">ude.fsu.csh@yekcolr</a></span>.</p><p><span class="fm-affl">Dennis Ledford, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@drofdeld" class="oemail">ude.fsu.csh@drofdeld</a></span>.</p><p><span class="fm-affl">Shyam S Mohapatra, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.fsu.csh@tapahoms" class="oemail">ude.fsu.csh@tapahoms</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Matsuse H, Behera AK, Kumar M, Lockey RF, Mohapatra SS. Differential cytokine mRNA expression in Dermatophagoides farinae allergen-sensitized and respiratory syncytial virus-infected mice. <span><span class="ref-journal">Microbes Infect. </span>2000;<span class="ref-vol">2</span>:753\xe2\x80\x93759. doi: 10.1016/S1286-4579(00)00500-1.</span> [<a href="/pubmed/10955955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1286-4579(00)00500-1" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Microbes+Infect&amp;title=Differential+cytokine+mRNA+expression+in+Dermatophagoides+farinae+allergen-sensitized+and+respiratory+syncytial+virus-infected+mice&amp;author=H+Matsuse&amp;author=AK+Behera&amp;author=M+Kumar&amp;author=RF+Lockey&amp;author=SS+Mohapatra&amp;volume=2&amp;publication_year=2000&amp;pages=753-759&amp;pmid=10955955&amp;doi=10.1016/S1286-4579(00)00500-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Kay AB. Asthma and inflammation. <span><span class="ref-journal">J Allergy Clin Immunol. </span>1991;<span class="ref-vol">87</span>:893\xe2\x80\x93910. doi: 10.1016/0091-6749(91)90408-G.</span> [<a href="/pubmed/2026843" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0091-6749(91)90408-G" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Asthma+and+inflammation&amp;author=AB+Kay&amp;volume=87&amp;publication_year=1991&amp;pages=893-910&amp;pmid=2026843&amp;doi=10.1016/0091-6749(91)90408-G&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Gern JE, Busse WW. The role of viral infections in the natural history of asthma. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2000;<span class="ref-vol">106</span>:201\xe2\x80\x93212. doi: 10.1067/mai.2000.108604.</span> [<a href="/pubmed/10932062" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1067%2Fmai.2000.108604" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=The+role+of+viral+infections+in+the+natural+history+of+asthma&amp;author=JE+Gern&amp;author=WW+Busse&amp;volume=106&amp;publication_year=2000&amp;pages=201-212&amp;pmid=10932062&amp;doi=10.1067/mai.2000.108604&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Minor TE, Dick EC, DeMeo AN, Ouellette JJ, Cohen M, Reed CE. Viruses as precipitants of asthmatic attacks in children. <span><span class="ref-journal">JAMA. </span>1974;<span class="ref-vol">227</span>:292\xe2\x80\x93298. doi: 10.1001/jama.1974.03230160020004.</span> [<a href="/pubmed/4358170" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1001%2Fjama.1974.03230160020004" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA&amp;title=Viruses+as+precipitants+of+asthmatic+attacks+in+children&amp;author=TE+Minor&amp;author=EC+Dick&amp;author=AN+DeMeo&amp;author=JJ+Ouellette&amp;author=M+Cohen&amp;volume=227&amp;publication_year=1974&amp;pages=292-298&amp;pmid=4358170&amp;doi=10.1001/jama.1974.03230160020004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Johnston SL, Pattemore PK, Sanderson G, Smith S, Campbell MJ, Josephs LK, Cunningham A, Robinson BS, Myint SH, Ward ME, Tyrrell DA, Holgate ST. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>1996;<span class="ref-vol">154</span>:654\xe2\x80\x93660. doi: 10.1164/ajrccm.154.3.8810601.</span> [<a href="/pubmed/8810601" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm.154.3.8810601" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=The+relationship+between+upper+respiratory+infections+and+hospital+admissions+for+asthma:+a+time-trend+analysis&amp;author=SL+Johnston&amp;author=PK+Pattemore&amp;author=G+Sanderson&amp;author=S+Smith&amp;author=MJ+Campbell&amp;volume=154&amp;publication_year=1996&amp;pages=654-660&amp;pmid=8810601&amp;doi=10.1164/ajrccm.154.3.8810601&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Rooney JC, Williams HE. The relationship between proved viral bronchiolitis and subsequent wheezing. <span><span class="ref-journal">J Pediatr. </span>1971;<span class="ref-vol">79</span>:744\xe2\x80\x93747. doi: 10.1016/S0022-3476(71)80385-2.</span> [<a href="/pubmed/5116699" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0022-3476(71)80385-2" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=The+relationship+between+proved+viral+bronchiolitis+and+subsequent+wheezing&amp;author=JC+Rooney&amp;author=HE+Williams&amp;volume=79&amp;publication_year=1971&amp;pages=744-747&amp;pmid=5116699&amp;doi=10.1016/S0022-3476(71)80385-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Gurwitz D, Mindorff C, Levison H. Increased incidence of bronchial reactivity in children with a history of bronchiolitis. <span><span class="ref-journal">J Pediatr. </span>1981;<span class="ref-vol">98</span>:551\xe2\x80\x93555. doi: 10.1016/S0022-3476(81)80758-5.</span> [<a href="/pubmed/7205480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0022-3476(81)80758-5" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Increased+incidence+of+bronchial+reactivity+in+children+with+a+history+of+bronchiolitis&amp;author=D+Gurwitz&amp;author=C+Mindorff&amp;author=H+Levison&amp;volume=98&amp;publication_year=1981&amp;pages=551-555&amp;pmid=7205480&amp;doi=10.1016/S0022-3476(81)80758-5&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Hall CB, Hall WJ, Gala CL, MaGill FB, Leddy JP. Long-term prospective study in children after respiratory syncytial virus infection. <span><span class="ref-journal">J Pediatr. </span>1984;<span class="ref-vol">105</span>:358\xe2\x80\x93364. doi: 10.1016/S0022-3476(84)80005-0.</span> [<a href="/pubmed/6470859" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0022-3476(84)80005-0" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Pediatr&amp;title=Long-term+prospective+study+in+children+after+respiratory+syncytial+virus+infection&amp;author=CB+Hall&amp;author=WJ+Hall&amp;author=CL+Gala&amp;author=FB+MaGill&amp;author=JP+Leddy&amp;volume=105&amp;publication_year=1984&amp;pages=358-364&amp;pmid=6470859&amp;doi=10.1016/S0022-3476(84)80005-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="element-citation">Mok JY, Simpson H. Symptoms, atopy, and bronchial reactivity after lower respiratory infection in infancy. <span><span class="ref-journal">Arch Dis Child. </span>1984;<span class="ref-vol">59</span>:299\xe2\x80\x93305. doi: 10.1136/adc.59.4.299.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1628658/">PMC free article</a>]</span> [<a href="/pubmed/6721554" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fadc.59.4.299" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dis+Child&amp;title=Symptoms,+atopy,+and+bronchial+reactivity+after+lower+respiratory+infection+in+infancy&amp;author=JY+Mok&amp;author=H+Simpson&amp;volume=59&amp;publication_year=1984&amp;pages=299-305&amp;pmid=6721554&amp;doi=10.1136/adc.59.4.299&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Webb MS, Henry RL, Milner AD, Stokes GM, Swarbrick AS. Continuing respiratory problems three and a half years after acute viral bronchiolitis. <span><span class="ref-journal">Arch Dis Child. </span>1985;<span class="ref-vol">60</span>:1064\xe2\x80\x931067. doi: 10.1136/adc.60.11.1064.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1777618/">PMC free article</a>]</span> [<a href="/pubmed/4073937" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fadc.60.11.1064" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Dis+Child&amp;title=Continuing+respiratory+problems+three+and+a+half+years+after+acute+viral+bronchiolitis&amp;author=MS+Webb&amp;author=RL+Henry&amp;author=AD+Milner&amp;author=GM+Stokes&amp;author=AS+Swarbrick&amp;volume=60&amp;publication_year=1985&amp;pages=1064-1067&amp;pmid=4073937&amp;doi=10.1136/adc.60.11.1064&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Welliver RC, Duffy L. The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7&#x02013;8 years. <span><span class="ref-journal">Pediatr Pulmonol. </span>1993;<span class="ref-vol">15</span>:19\xe2\x80\x9327. doi: 10.1002/ppul.1950150104.</span> [<a href="/pubmed/8419894" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fppul.1950150104" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Pulmonol&amp;title=The+relationship+of+RSV-specific+immunoglobulin+E+antibody+responses+in+infancy,+recurrent+wheezing,+and+pulmonary+function+at+age+7&#x02013;8+years&amp;author=RC+Welliver&amp;author=L+Duffy&amp;volume=15&amp;publication_year=1993&amp;pages=19-27&amp;pmid=8419894&amp;doi=10.1002/ppul.1950150104&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B, Bjorksten B. Asthma and immunoglobulin E antibodies after respiratory syncytial virus bronchiolitis: a prospective cohort study with matched controls. <span><span class="ref-journal">Pediatrics. </span>1995;<span class="ref-vol">95</span>:500\xe2\x80\x93505.</span> [<a href="/pubmed/7700748" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatrics&amp;title=Asthma+and+immunoglobulin+E+antibodies+after+respiratory+syncytial+virus+bronchiolitis:+a+prospective+cohort+study+with+matched+controls&amp;author=N+Sigurs&amp;author=R+Bjarnason&amp;author=F+Sigurbergsson&amp;author=B+Kjellman&amp;author=B+Bjorksten&amp;volume=95&amp;publication_year=1995&amp;pages=500-505&amp;pmid=7700748&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Graham BS, Bunton LA, Wright PF, Karzon DT. Reinfection of mice with respiratory syncytial virus. <span><span class="ref-journal">J Med Virol. </span>1991;<span class="ref-vol">34</span>:7\xe2\x80\x9313. doi: 10.1002/jmv.1890340103.</span> [<a href="/pubmed/1885946" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fjmv.1890340103" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Virol&amp;title=Reinfection+of+mice+with+respiratory+syncytial+virus&amp;author=BS+Graham&amp;author=LA+Bunton&amp;author=PF+Wright&amp;author=DT+Karzon&amp;volume=34&amp;publication_year=1991&amp;pages=7-13&amp;pmid=1885946&amp;doi=10.1002/jmv.1890340103&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, Symington P, O\'Toole S, Myint SH, Tyrrell DA, Holgate ST. Community study of role of viral infections in exacerbations of asthma in 9&#x02013;11 year old children. <span><span class="ref-journal">BMJ. </span>1995;<span class="ref-vol">310</span>:1225\xe2\x80\x931129. doi: 10.1136/bmj.310.6989.1225.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2549614/">PMC free article</a>]</span> [<a href="/pubmed/7767192" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1136%2Fbmj.310.6989.1225" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMJ&amp;title=Community+study+of+role+of+viral+infections+in+exacerbations+of+asthma+in+9&#x02013;11+year+old+children&amp;author=SL+Johnston&amp;author=PK+Pattemore&amp;author=G+Sanderson&amp;author=S+Smith&amp;author=F+Lampe&amp;volume=310&amp;publication_year=1995&amp;pages=1225-1129&amp;pmid=7767192&amp;doi=10.1136/bmj.310.6989.1225&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">Wray BB. Asthma: best treatment options. <span><span class="ref-journal">Ann Allergy Asthma Immunol. </span>2001;<span class="ref-vol">87</span>:9\xe2\x80\x9312. doi: 10.1016/S1081-1206(10)62189-8.</span> [<a href="/pubmed/11476480" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1081-1206(10)62189-8" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Allergy+Asthma+Immunol&amp;title=Asthma:+best+treatment+options&amp;author=BB+Wray&amp;volume=87&amp;publication_year=2001&amp;pages=9-12&amp;pmid=11476480&amp;doi=10.1016/S1081-1206(10)62189-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Nelson HS. Combination therapy of bronchial asthma. <span><span class="ref-journal">Allergy Asthma Proc. </span>2001;<span class="ref-vol">22</span>:217\xe2\x80\x93220.</span> [<a href="/pubmed/11552671" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Allergy+Asthma+Proc&amp;title=Combination+therapy+of+bronchial+asthma&amp;author=HS+Nelson&amp;volume=22&amp;publication_year=2001&amp;pages=217-220&amp;pmid=11552671&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. <span><span class="ref-journal">Eur Respir J. </span>2002;<span class="ref-vol">19</span>:182\xe2\x80\x93191. doi: 10.1183/09031936.02.00283202.</span> [<a href="/pubmed/11843317" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1183%2F09031936.02.00283202" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Scientific+rationale+for+inhaled+combination+therapy+with+long-acting+beta2-agonists+and+corticosteroids&amp;author=PJ+Barnes&amp;volume=19&amp;publication_year=2002&amp;pages=182-191&amp;pmid=11843317&amp;doi=10.1183/09031936.02.00283202&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Lyseng-Williamson KA, Plosker GL. Inhaled salmeterol/fluticasone propionate combination: a pharmacoeconomic review of its use in the management of asthma. <span><span class="ref-journal">Pharmacoeconomics. </span>2003;<span class="ref-vol">21</span>:951\xe2\x80\x93989. doi: 10.2165/00019053-200321130-00004.</span> [<a href="/pubmed/12959627" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2165%2F00019053-200321130-00004" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacoeconomics&amp;title=Inhaled+salmeterol/fluticasone+propionate+combination:+a+pharmacoeconomic+review+of+its+use+in+the+management+of+asthma&amp;author=KA+Lyseng-Williamson&amp;author=GL+Plosker&amp;volume=21&amp;publication_year=2003&amp;pages=951-989&amp;pmid=12959627&amp;doi=10.2165/00019053-200321130-00004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Eickelberg O, Roth M, Lorx R, Bruce V, Rudiger J, Johnson M, Block LH. Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells. <span><span class="ref-journal">J Biol Chem. </span>1999;<span class="ref-vol">274</span>:1005\xe2\x80\x931010. doi: 10.1074/jbc.274.2.1005.</span> [<a href="/pubmed/9873044" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1074%2Fjbc.274.2.1005" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Biol+Chem&amp;title=Ligand-independent+activation+of+the+glucocorticoid+receptor+by+beta2-adrenergic+receptor+agonists+in+primary+human+lung+fibroblasts+and+vascular+smooth+muscle+cells&amp;author=O+Eickelberg&amp;author=M+Roth&amp;author=R+Lorx&amp;author=V+Bruce&amp;author=J+Rudiger&amp;volume=274&amp;publication_year=1999&amp;pages=1005-1010&amp;pmid=9873044&amp;doi=10.1074/jbc.274.2.1005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Goleva E, Dunlap A, Leung DY. Differential control of TH1 versus TH2 cell responses by the combination of low-dose steroids with beta2-adrenergic agonists. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2004;<span class="ref-vol">114</span>:183\xe2\x80\x93191. doi: 10.1016/j.jaci.2004.04.001.</span> [<a href="/pubmed/15241363" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jaci.2004.04.001" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Differential+control+of+TH1+versus+TH2+cell+responses+by+the+combination+of+low-dose+steroids+with+beta2-adrenergic+agonists&amp;author=E+Goleva&amp;author=A+Dunlap&amp;author=DY+Leung&amp;volume=114&amp;publication_year=2004&amp;pages=183-191&amp;pmid=15241363&amp;doi=10.1016/j.jaci.2004.04.001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">McKean M, Ducharme F.  <span class="ref-journal">Cochrane Database Syst Rev.</span> 2000. Inhaled steroids for episodic viral wheeze of childhood; p. CD001107. [<a href="/pubmed/10796596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?title=Cochrane+Database+Syst+Rev&amp;author=M+McKean&amp;author=F+Ducharme&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Dowling RB, Johnson M, Cole PJ, Wilson R. Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro. <span><span class="ref-journal">Eur Respir J. </span>1999;<span class="ref-vol">14</span>:363\xe2\x80\x93369. doi: 10.1034/j.1399-3003.1999.14b21.x.</span> [<a href="/pubmed/10515415" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1034%2Fj.1399-3003.1999.14b21.x" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+Respir+J&amp;title=Effect+of+fluticasone+propionate+and+salmeterol+on+Pseudomonas+aeruginosa+infection+of+the+respiratory+mucosa+in+vitro&amp;author=RB+Dowling&amp;author=M+Johnson&amp;author=PJ+Cole&amp;author=R+Wilson&amp;volume=14&amp;publication_year=1999&amp;pages=363-369&amp;pmid=10515415&amp;doi=10.1034/j.1399-3003.1999.14b21.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Zhao J, Takamura M, Yamaoka A, Odajima Y, Iikura Y. Altered eosinophil levels as a result of viral infection in asthma exacerbation in childhood. <span><span class="ref-journal">Pediatr Allergy Immunol. </span>2002;<span class="ref-vol">13</span>:47\xe2\x80\x9350. doi: 10.1034/j.1399-3038.2002.00051.x.</span> [<a href="/pubmed/12000498" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1034%2Fj.1399-3038.2002.00051.x" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Allergy+Immunol&amp;title=Altered+eosinophil+levels+as+a+result+of+viral+infection+in+asthma+exacerbation+in+childhood&amp;author=J+Zhao&amp;author=M+Takamura&amp;author=A+Yamaoka&amp;author=Y+Odajima&amp;author=Y+Iikura&amp;volume=13&amp;publication_year=2002&amp;pages=47-50&amp;pmid=12000498&amp;doi=10.1034/j.1399-3038.2002.00051.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Noah TL, Wortman IA, Becker S. The effect of fluticasone propionate on respiratory syncytial virus-induced chemokine release by a human bronchial epithelial cell line. <span><span class="ref-journal">Immunopharmacology. </span>1998;<span class="ref-vol">39</span>:193\xe2\x80\x93199. doi: 10.1016/S0162-3109(98)00017-4.</span> [<a href="/pubmed/9754905" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0162-3109(98)00017-4" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunopharmacology&amp;title=The+effect+of+fluticasone+propionate+on+respiratory+syncytial+virus-induced+chemokine+release+by+a+human+bronchial+epithelial+cell+line&amp;author=TL+Noah&amp;author=IA+Wortman&amp;author=S+Becker&amp;volume=39&amp;publication_year=1998&amp;pages=193-199&amp;pmid=9754905&amp;doi=10.1016/S0162-3109(98)00017-4&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Panitch HB. Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction. <span><span class="ref-journal">Pediatr Infect Dis J. </span>2003;<span class="ref-vol">22</span>:S83\xe2\x80\x9387.</span> [<a href="/pubmed/12671457" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pediatr+Infect+Dis+J&amp;title=Respiratory+syncytial+virus+bronchiolitis:+supportive+care+and+therapies+designed+to+overcome+airway+obstruction&amp;author=HB+Panitch&amp;volume=22&amp;publication_year=2003&amp;pages=S83-87&amp;pmid=12671457&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Steiner RW. Treating acute bronchiolitis associated with RSV. <span><span class="ref-journal">Am Fam Physician. </span>2004;<span class="ref-vol">69</span>:325\xe2\x80\x93330.</span> [<a href="/pubmed/14765771" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+Fam+Physician&amp;title=Treating+acute+bronchiolitis+associated+with+RSV&amp;author=RW+Steiner&amp;volume=69&amp;publication_year=2004&amp;pages=325-330&amp;pmid=14765771&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Kabra SK, Lodha R. Management of unresponsive asthma. <span><span class="ref-journal">Indian J Pediatr. </span>2004;<span class="ref-vol">71</span>:729\xe2\x80\x93732. doi: 10.1007/BF02730664.</span> [<a href="/pubmed/15345875" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2FBF02730664" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Indian+J+Pediatr&amp;title=Management+of+unresponsive+asthma&amp;author=SK+Kabra&amp;author=R+Lodha&amp;volume=71&amp;publication_year=2004&amp;pages=729-732&amp;pmid=15345875&amp;doi=10.1007/BF02730664&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Jafri HS, Chavez-Bueno S, Mejias A, Gomez AM, Rios AM, Nassi SS, Yusuf M, Kapur P, Hardy RD, Hatfield J, Rogers BB, Krisher K, Ramilo O. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice. <span><span class="ref-journal">J Infect Dis. </span>2004;<span class="ref-vol">189</span>:1856\xe2\x80\x931865. doi: 10.1086/386372.</span> [<a href="/pubmed/15122522" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F386372" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Respiratory+syncytial+virus+induces+pneumonia,+cytokine+response,+airway+obstruction,+and+chronic+inflammatory+infiltrates+associated+with+long-term+airway+hyperresponsiveness+in+mice&amp;author=HS+Jafri&amp;author=S+Chavez-Bueno&amp;author=A+Mejias&amp;author=AM+Gomez&amp;author=AM+Rios&amp;volume=189&amp;publication_year=2004&amp;pages=1856-1865&amp;pmid=15122522&amp;doi=10.1086/386372&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Krishnan S, Craven M, Welliver RC, Ahmad N, Halonen M. Differences in participation of innate and adaptive immunity to respiratory syncytial virus in adults and neonates. <span><span class="ref-journal">J Infect Dis. </span>2003;<span class="ref-vol">188</span>:433\xe2\x80\x93439. doi: 10.1086/376530.</span> [<a href="/pubmed/12870126" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1086%2F376530" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Differences+in+participation+of+innate+and+adaptive+immunity+to+respiratory+syncytial+virus+in+adults+and+neonates&amp;author=S+Krishnan&amp;author=M+Craven&amp;author=RC+Welliver&amp;author=N+Ahmad&amp;author=M+Halonen&amp;volume=188&amp;publication_year=2003&amp;pages=433-439&amp;pmid=12870126&amp;doi=10.1086/376530&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2003;<span class="ref-vol">168</span>:633\xe2\x80\x93639. doi: 10.1164/rccm.200210-1148OC.</span> [<a href="/pubmed/12773328" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Frccm.200210-1148OC" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Type+1+and+type+2+cytokine+imbalance+in+acute+respiratory+syncytial+virus+bronchiolitis&amp;author=JP+Legg&amp;author=IR+Hussain&amp;author=JA+Warner&amp;author=SL+Johnston&amp;author=JO+Warner&amp;volume=168&amp;publication_year=2003&amp;pages=633-639&amp;pmid=12773328&amp;doi=10.1164/rccm.200210-1148OC&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, Geelen SM, Kimpen JL. Monocyte IL-10 production during respiratory syncytial virus bronchiolitis is associated with recurrent wheezing in a one-year follow-up study. <span><span class="ref-journal">Am J Respir Crit Care Med. </span>2000;<span class="ref-vol">161</span>:1518\xe2\x80\x931523. doi: 10.1164/ajrccm.161.5.9904078.</span> [<a href="/pubmed/10806148" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1164%2Fajrccm.161.5.9904078" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Respir+Crit+Care+Med&amp;title=Monocyte+IL-10+production+during+respiratory+syncytial+virus+bronchiolitis+is+associated+with+recurrent+wheezing+in+a+one-year+follow-up+study&amp;author=L+Bont&amp;author=CJ+Heijnen&amp;author=A+Kavelaars&amp;author=WM+van+Aalderen&amp;author=F+Brus&amp;volume=161&amp;publication_year=2000&amp;pages=1518-1523&amp;pmid=10806148&amp;doi=10.1164/ajrccm.161.5.9904078&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Bont L, Aalderen WM, Kimpen JL. Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. <span><span class="ref-journal">Paediatr Respir Rev. </span>2000;<span class="ref-vol">1</span>:221\xe2\x80\x93227.</span> [<a href="/pubmed/12531083" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Paediatr+Respir+Rev&amp;title=Long-term+consequences+of+respiratory+syncytial+virus+(RSV)+bronchiolitis&amp;author=L+Bont&amp;author=WM+Aalderen&amp;author=JL+Kimpen&amp;volume=1&amp;publication_year=2000&amp;pages=221-227&amp;pmid=12531083&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Sabatini F, Silvestri M, Sale R, Serpero L, Giuliani M, Scarso L, Favini P, Rossi GA. Concentration-dependent effects of mometasone furoate and dexamethasone on foetal lung fibroblast functions involved in airway inflammation and remodeling. <span><span class="ref-journal">Pulm Pharmacol Ther. </span>2003;<span class="ref-vol">16</span>:287\xe2\x80\x93297. doi: 10.1016/S1094-5539(03)00068-3.</span> [<a href="/pubmed/12877820" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1094-5539(03)00068-3" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pulm+Pharmacol+Ther&amp;title=Concentration-dependent+effects+of+mometasone+furoate+and+dexamethasone+on+foetal+lung+fibroblast+functions+involved+in+airway+inflammation+and+remodeling&amp;author=F+Sabatini&amp;author=M+Silvestri&amp;author=R+Sale&amp;author=L+Serpero&amp;author=M+Giuliani&amp;volume=16&amp;publication_year=2003&amp;pages=287-297&amp;pmid=12877820&amp;doi=10.1016/S1094-5539(03)00068-3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Ek A, Larsson K, Siljerud S, Palmberg L. Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages. <span><span class="ref-journal">Allergy. </span>1999;<span class="ref-vol">54</span>:691\xe2\x80\x93699. doi: 10.1034/j.1398-9995.1999.00087.x.</span> [<a href="/pubmed/10442524" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1034%2Fj.1398-9995.1999.00087.x" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Allergy&amp;title=Fluticasone+and+budesonide+inhibit+cytokine+release+in+human+lung+epithelial+cells+and+alveolar+macrophages&amp;author=A+Ek&amp;author=K+Larsson&amp;author=S+Siljerud&amp;author=L+Palmberg&amp;volume=54&amp;publication_year=1999&amp;pages=691-699&amp;pmid=10442524&amp;doi=10.1034/j.1398-9995.1999.00087.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Roe MF, Bloxham DM, White DK, Ross-Russell RI, Tasker RT, O\'Donnell DR. Lymphocyte apoptosis in acute respiratory syncytial virus bronchiolitis. <span><span class="ref-journal">Clin Exp Immunol. </span>2004;<span class="ref-vol">137</span>:139\xe2\x80\x93145. doi: 10.1111/j.1365-2249.2004.02512.x.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1809083/">PMC free article</a>]</span> [<a href="/pubmed/15196254" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1111%2Fj.1365-2249.2004.02512.x" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Exp+Immunol&amp;title=Lymphocyte+apoptosis+in+acute+respiratory+syncytial+virus+bronchiolitis&amp;author=MF+Roe&amp;author=DM+Bloxham&amp;author=DK+White&amp;author=RI+Ross-Russell&amp;author=RT+Tasker&amp;volume=137&amp;publication_year=2004&amp;pages=139-145&amp;pmid=15196254&amp;doi=10.1111/j.1365-2249.2004.02512.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Pace E, Gagliardo R, Melis M, La Grutta S, Ferraro M, Siena L, Bonsignore G, Gjomarkaj M, Bousquet J, Vignola AM. Synergistic effects of fluticasone propionate and salmeterol on in vitro T-cell activation and apoptosis in asthma. <span><span class="ref-journal">J Allergy Clin Immunol. </span>2004;<span class="ref-vol">114</span>:1216\xe2\x80\x931223. doi: 10.1016/j.jaci.2004.07.052.</span> [<a href="/pubmed/15536434" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jaci.2004.07.052" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Allergy+Clin+Immunol&amp;title=Synergistic+effects+of+fluticasone+propionate+and+salmeterol+on+in+vitro+T-cell+activation+and+apoptosis+in+asthma&amp;author=E+Pace&amp;author=R+Gagliardo&amp;author=M+Melis&amp;author=S+La+Grutta&amp;author=M+Ferraro&amp;volume=114&amp;publication_year=2004&amp;pages=1216-1223&amp;pmid=15536434&amp;doi=10.1016/j.jaci.2004.07.052&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">Kumar M, Behera A, Matsuse H, Lockey R, Mohapatra SS. Intranasal IFN-g transfer of prevents respiratory syncytial virus infection in BALB/c mice. <span><span class="ref-journal">Vaccine. </span>1999;<span class="ref-vol">18</span>:558\xe2\x80\x93567. doi: 10.1016/S0264-410X(99)00185-1.</span> [<a href="/pubmed/10519947" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0264-410X(99)00185-1" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Intranasal+IFN-g+transfer+of+prevents+respiratory+syncytial+virus+infection+in+BALB/c+mice&amp;author=M+Kumar&amp;author=A+Behera&amp;author=H+Matsuse&amp;author=R+Lockey&amp;author=SS+Mohapatra&amp;volume=18&amp;publication_year=1999&amp;pages=558-567&amp;pmid=10519947&amp;doi=10.1016/S0264-410X(99)00185-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR38">38. <span class="element-citation">Kumar M, Behera AK, Lockey RF, Zhang J, Perez de la Cruz C, Chen l, Leong KW, Huang S-K, Mohapatra SS. Intranasal gene transfer by chitosan-DNA nanospheres protects BALB\\C mice against acute respiratory syncytial virus infection. <span><span class="ref-journal">Human Gene Therapy. </span>2002;<span class="ref-vol">13</span>:1415\xe2\x80\x931425. doi: 10.1089/10430340260185058.</span> [<a href="/pubmed/12215263" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1089%2F10430340260185058" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Human+Gene+Therapy&amp;title=Intranasal+gene+transfer+by+chitosan-DNA+nanospheres+protects+BALB\\C+mice+against+acute+respiratory+syncytial+virus+infection&amp;author=M+Kumar&amp;author=AK+Behera&amp;author=RF+Lockey&amp;author=J+Zhang&amp;author=C+Perez+de+la+Cruz&amp;volume=13&amp;publication_year=2002&amp;pages=1415-1425&amp;pmid=12215263&amp;doi=10.1089/10430340260185058&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR39">39. <span class="element-citation">Kumar M, Kong X, Behera A, Hellermann G, Lockey RF, Mohapatra SS. Chitosan IFN-&#x003b3;-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma. <span><span class="ref-journal">Genetic Vaccines and Therapy. </span>2003;<span class="ref-vol">1</span>:3. doi: 10.1186/1479-0556-1-3.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC280670/">PMC free article</a>]</span> [<a href="/pubmed/14613519" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1479-0556-1-3" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Genetic+Vaccines+and+Therapy&amp;title=Chitosan+IFN-&#x003b3;-pDNA+Nanoparticle+(CIN)+Therapy+for+Allergic+Asthma&amp;author=M+Kumar&amp;author=X+Kong&amp;author=A+Behera&amp;author=G+Hellermann&amp;author=RF+Lockey&amp;volume=1&amp;publication_year=2003&amp;pages=3&amp;pmid=14613519&amp;doi=10.1186/1479-0556-1-3&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR40">40. <span class="element-citation">Zhang W, Yang H, Kong X, Mohapatra S, Juan-Vergara HS, Hellermann G, Behera S, Singam R, Lockey RF, Mohapatra SS. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. <span><span class="ref-journal">Nature Medicine. </span>2005;<span class="ref-vol">11</span>:56\xe2\x80\x9362. doi: 10.1038/nm1174.</span> [<a href="/pubmed/15619625" target="pmc_ext" ref="reftype=pubmed&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnm1174" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature+Medicine&amp;title=Inhibition+of+respiratory+syncytial+virus+infection+with+intranasal+siRNA+nanoparticles+targeting+the+viral+NS1+gene&amp;author=W+Zhang&amp;author=H+Yang&amp;author=X+Kong&amp;author=S+Mohapatra&amp;author=HS+Juan-Vergara&amp;volume=11&amp;publication_year=2005&amp;pages=56-62&amp;pmid=15619625&amp;doi=10.1038/nm1174&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=1488829&amp;issue-id=354810&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC1488829/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC1488829/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC1488829/pdf/12985_2006_Article_139.pdf">PDF (2.2M)</a></li> | <li><a href="#" data-citationid="PMC1488829" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1488829%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1488829%2F&amp;text=Combined%20fluticasone%20propionate%20and%20salmeterol%20reduces%20RSV%20infection%20more%20effectively%20than%20either%20of%20them%20alone%20in%20allergen-sensitized%20mice"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1488829%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="16719922" data-aiid="7095692" data-aid="1488829" data-iid="354810" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC1488829" data-md5="888e9b36bf0eeea04074bb1e05f7f43c"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:16:19-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1BD4E8E999FD710000000006AE06AD&amp;ncbi_session=8A1BD4E8E99AC221_1710SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1488829%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC1488829/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1BD4E8E99AC221_1710SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'